GMOEX vs. EFEIX
Compare and contrast key facts about GMO Emerging Markets Fund (GMOEX) and Ashmore Emerging Markets Frontier Equity Fund (EFEIX).
GMOEX is managed by GMO. It was launched on Dec 8, 1993. EFEIX is managed by Ashmore. It was launched on Nov 3, 2013.
Performance
GMOEX vs. EFEIX - Performance Comparison
Loading graphics...
GMOEX vs. EFEIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GMOEX GMO Emerging Markets Fund | 2.77% | 33.86% | 1.95% | 17.68% | -31.57% | 2.05% | 5.50% | 22.15% | -12.82% | 32.05% |
EFEIX Ashmore Emerging Markets Frontier Equity Fund | -4.81% | 20.69% | 24.12% | 10.60% | -15.91% | 24.18% | -4.12% | 14.07% | -18.04% | 19.28% |
Returns By Period
In the year-to-date period, GMOEX achieves a 2.77% return, which is significantly higher than EFEIX's -4.81% return. Over the past 10 years, GMOEX has underperformed EFEIX with an annualized return of 6.26%, while EFEIX has yielded a comparatively higher 6.72% annualized return.
GMOEX
- 1D
- -0.97%
- 1M
- -12.62%
- YTD
- 2.77%
- 6M
- 8.09%
- 1Y
- 33.37%
- 3Y*
- 17.00%
- 5Y*
- 1.70%
- 10Y*
- 6.26%
EFEIX
- 1D
- -0.39%
- 1M
- -10.76%
- YTD
- -4.81%
- 6M
- -1.64%
- 1Y
- 12.63%
- 3Y*
- 15.99%
- 5Y*
- 9.66%
- 10Y*
- 6.72%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
GMOEX vs. EFEIX - Expense Ratio Comparison
GMOEX has a 0.90% expense ratio, which is lower than EFEIX's 1.52% expense ratio.
Return for Risk
GMOEX vs. EFEIX — Risk / Return Rank
GMOEX
EFEIX
GMOEX vs. EFEIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GMO Emerging Markets Fund (GMOEX) and Ashmore Emerging Markets Frontier Equity Fund (EFEIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GMOEX | EFEIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.95 | 1.00 | +0.95 |
Sortino ratioReturn per unit of downside risk | 2.43 | 1.36 | +1.07 |
Omega ratioGain probability vs. loss probability | 1.38 | 1.19 | +0.18 |
Calmar ratioReturn relative to maximum drawdown | 2.26 | 1.03 | +1.23 |
Martin ratioReturn relative to average drawdown | 8.69 | 3.59 | +5.10 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GMOEX | EFEIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.95 | 1.00 | +0.95 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.11 | 1.00 | -0.89 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.38 | 0.62 | -0.24 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.36 | -0.23 |
Correlation
The correlation between GMOEX and EFEIX is 0.54, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
GMOEX vs. EFEIX - Dividend Comparison
GMOEX's dividend yield for the trailing twelve months is around 4.88%, less than EFEIX's 11.96% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GMOEX GMO Emerging Markets Fund | 4.88% | 5.01% | 3.79% | 6.00% | 8.08% | 4.48% | 3.71% | 4.63% | 3.36% | 2.56% | 2.21% | 1.15% |
EFEIX Ashmore Emerging Markets Frontier Equity Fund | 11.96% | 11.69% | 2.15% | 2.26% | 0.17% | 1.61% | 0.96% | 1.63% | 1.44% | 0.88% | 0.38% | 0.00% |
Drawdowns
GMOEX vs. EFEIX - Drawdown Comparison
The maximum GMOEX drawdown since its inception was -76.43%, which is greater than EFEIX's maximum drawdown of -40.50%. Use the drawdown chart below to compare losses from any high point for GMOEX and EFEIX.
Loading graphics...
Drawdown Indicators
| GMOEX | EFEIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.43% | -40.50% | -35.93% |
Max Drawdown (1Y)Largest decline over 1 year | -13.38% | -11.62% | -1.76% |
Max Drawdown (5Y)Largest decline over 5 years | -43.50% | -20.83% | -22.67% |
Max Drawdown (10Y)Largest decline over 10 years | -43.50% | -40.50% | -3.00% |
Current DrawdownCurrent decline from peak | -29.92% | -11.62% | -18.30% |
Average DrawdownAverage peak-to-trough decline | -37.56% | -12.38% | -25.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.48% | 3.32% | +0.16% |
Volatility
GMOEX vs. EFEIX - Volatility Comparison
GMO Emerging Markets Fund (GMOEX) has a higher volatility of 7.68% compared to Ashmore Emerging Markets Frontier Equity Fund (EFEIX) at 6.28%. This indicates that GMOEX's price experiences larger fluctuations and is considered to be riskier than EFEIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| GMOEX | EFEIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.68% | 6.28% | +1.40% |
Volatility (6M)Calculated over the trailing 6-month period | 12.16% | 8.74% | +3.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.76% | 12.26% | +4.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.84% | 9.69% | +6.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.61% | 10.93% | +5.68% |